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Background: Heart muscle primarily relies on adenosine triphosphate pro-
duced by oxidative phosphorylation and is highly vulnerable to anoxic insult.
Although a number of strategies aimed at improving myopreservation are
available, no effective means of preserving mitochondrial energetics under
conditions of anoxic injury have been developed. Openers of mitochondrial
adenosine triphosphate–sensitive potassium channels have emerged as pow-
erful cardioprotective agents presumably capable of maintaining mitochon-
drial function under metabolic stress. Here, we evaluated the ability of a pro-
totype mitochondrial adenosine triphosphate–sensitive potassium channel
opener, diazoxide, to preserve oxidative phosphorylation in mitochondria
subjected to anoxia and reoxygenation.
Methods: Mitochondria were isolated from rat hearts and subjected to 20
minutes of anoxia, followed by reoxygenation. Mitochondrial respiration
and oxidative phosphorylation, as well as mitochondrial integrity, were
assessed by means of ion-selective minielectrodes, high-performance liquid
chromatography, fluorometry, and electron microscopy.
Results: Anoxia-reoxygenation decreased the rate of adenosine diphos-
phate–stimulated oxygen consumption, inhibited adenosine triphosphate
production, and disrupted mitochondrial integrity. On average, anoxic stress
reduced adenosine diphosphate–stimulated respiration from 291 ± 14 to
141 ± 15 ng-atoms O2 · min–1 · mg–1 protein and decreased the rate of adeno-
sine triphosphate production from 752 ± 14 to 414 ± 34 nmol adenosine
triphosphate · min–1 · mg–1 protein. After anoxia, the majority (88%) of mito-
chondria was damaged or swollen and released adenylate kinase, a marker of
mitochondrial integrity. Diazoxide (100 µmol/L), present throughout anox-
ia, preserved adenosine diphosphate–stimulated respiration at 255 ± 7 ng-
atoms O2 · min–1 · mg–1 protein and adenosine triphosphate production at
640 ± 39 nmol adenosine triphosphate · min–1 · mg–1 protein. Diazoxide also
protected mitochondrial structure from anoxia-mediated damage, so that
after anoxic stress, 67% of mitochondria remained intact and adenylate
kinase was confined to the mitochondria.
Conclusions: The present study demonstrates that diazoxide diminishes
anoxia-induced functional and structural deterioration of cardiac mitochon-
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T he inherent vulnerability of cardiomyocytes to oxy-gen deprivation and metabolic stress contributes to
myocardial dysfunction in cardiac operations and car-
diac transplantation.1 Optimal myocardial function
requires adequate supply of intracellular adenosine
triphosphate (ATP), which is generated primarily by
mitochondria through oxidative phosphorylation.2
Conditions associated with decreased oxygen supply,
as observed in global surgical ischemia or ex vivo stor-
age of donor heart, can severely compromise mito-
chondrial energetics and precipitate cell injury.3-5
Although a number of strategies aimed at improving
cardiopreservation have been proposed,1,6-10 no effec-
tive means of preserving mitochondrial ATP production
under conditions of anoxic injury have been developed.
Pretreatment with mitochondrial ATP-sensitive potas-
sium (KATP) channel openers has recently emerged as a
promising approach in preserving myocardial function
in the surgically relevant setting of prolonged
ischemia.11 The prototype mitochondrial KATP channel
opener diazoxide has been found to reduce infarct size
in the whole heart, protect right atrial myocardium, and
enhance survival of single cardiomyocytes.12-14 How-
ever, it remains controversial whether potassium chan-
nel openers can maintain mitochondrial ATP synthesis
under conditions of metabolic stress.15-19
Here we provide direct evidence that diazoxide main-
tains the functional and structural integrity of isolated
cardiac mitochondria exposed to anoxia-reoxygena-
tion. By targeting mitochondria and preserving oxida-
tive ATP synthesis, diazoxide-like agents would pre-
serve bioenergetics and thereby provide added
protection in cardiac operations.
Methods
The investigation conformed to the “Guide for the Care and
Use of Laboratory Animals” prepared by the Institute of
Laboratory Animal Resources, National Research Council,
and published by the National Academy Press, revised 1996,
and was approved by the Institutional Animal Care and Use
Committee.
Isolation of mitochondria. Mitochondria were isolated
from hearts of sodium pentobarbital–anesthetized (100 mg/kg
administered intraperitoneally) rats (Harlan Sprague-Dawley,
Indianapolis, Ind), as previously described.15,20 In brief, ven-
tricles were removed into an ice-cold buffer (sucrose, 50
mmol/L; mannitol, 200 mmol/L; KH2PO4, 5 mmol/L; ethyl-
eneglycol-bis-(β-aminoethylether)-N,N,N´,N´-tetraacetic
acid, 1 mmol/L; 3(N-Morpholino)propanesulfonic acid
(MOPS), 5 mmol/L [pH 7.3]; and 0.2% bovine serum albu-
min) and homogenized (PT 10/35 Polytron; Brinkman
Instruments, Westbury, NY), and mitochondria were separat-
ed by means of centrifugation (Sorvall RCSC; Kendro
Laboratory Products, Newtown, Conn). To increase mito-
chondrial yield, the obtained pellet was rehomogenized
(Potter-Elvehjem homogenizer) and centrifuged. Resulting
supernatants were centrifuged, and mitochondria were
washed in isolation buffer (without ethyleneglycol-bis-[β-
aminoethylether]-N,N,N´,N´-tetraacetic acid and bovine
serum albumin) and kept on ice. Protein concentration was
determined with a DC protein kit (Bio-Rad, Hercules, Calif).
Anoxia-reoxygenation protocol. Mitochondria (2 mg of
protein) were added into an air-tight, closed, multichannel
chamber “ESON-6CH” filled with 1 mL of incubation medi-
um (KCl, 110 mmol/L; KH2PO4, 5 mmol/L; pyruvate, 2.5
mmol/L; malate, 2.5 mmol/L; and MOPS, 10 mmol/L [pH
7.3]) and continuously stirred at 30°C.15,20 Anoxia was
reached within 5 minutes as mitochondria consumed all
available oxygen in the chamber. Throughout the anoxic
interval (20 minutes), the oxygen level was at zero within the
closed chamber containing the mitochondrial suspension.
After the 20-minute anoxic period, mitochondrial suspension
was exposed to room air to achieve reoxygenation.21
Mitochondrial oxygen consumption and membrane
potential. Mitochondrial respiration and membrane potential
were continuously monitored by means of oxygen and
tetraphenylphosphonium-selective minielectrodes,15,20 and
data were acquired and processed by use of the Bioquest soft-
ware.22 Mitochondrial respiration was determined in the
absence (state 2, V2) or presence (state 3, V3) of 250 µmol/L
adenosine diphosphate (ADP). The maximal respiratory
capacity of mitochondria was determined after a challenge
with 50 µmol/L 2,4-dinitrophenol (DNP), a mitochondrial
uncoupler. Mitochondrial membrane potential was calculated
according to the following equation:
∆Ψ = 59log(v/V) – 59log(10(E–Eo)/59 – 1)
in which ∆Ψ is membrane potential (in millivolts), v is mito-
chondrial matrix volume (1.6 µL/mg mitochondrial protein),
V is volume of incubation medium (1 mL), and Eo and E are
electrode potentials before and after addition of mitochon-
dria, respectively.
ATP levels. ATP levels were measured in K2CO3-
MOPS–neutralized HClO4-soluble mitochondrial extracts by
means of high-pressure liquid chromatography (Hewlett
dria. By protecting mitochondria and preserving myocardial energetics,
diazoxide may be useful under conditions of reduced oxygen availability,
including global surgical ischemia or storage of donor heart. (J Thorac
Cardiovasc Surg 2001;121:298-306)
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Packard, Waldbronn, Germany), as previously described.23 In
addition, the kinetics of ADP to ATP conversion were moni-
tored in mitochondrial suspension as changes in reduced
nicotinamide adenine dinucleotide phosphate fluorescence in
a coupled hexokinase/glucose-6-phosphate dehydrogenase
ATP assay by a multiplate reader (Ascent FL; Scientific
Resources, St Paul, Minn).
Enzyme activity. Mitochondrial suspension was cen-
trifuged, and release of adenylate kinase was monitored in the
supernatant and pellet. Adenylate kinase activity was mea-
sured with a multiplate reader (Ascent FL) in 100 mmol/L
potassium acetate, 20 mmol/L –2-hydroxyethylpiperazine-N-
2-ethanesulfonic acid (pH 7.5), 20 mmol/L glucose, 4
mmol/L MgCl2, 2 mmol/L nictoinamide adenine dinucleotide
phosphate, 1 mmol/L ethylenediamine tetraacetic acid, 1
mmol/L dithiothreitol, 4.5 U/mL hexokinase, and 2 U/mL
glucose-6-phosphate dehydrogenase, and the reaction was
initiated with 2 mmol/L ADP.23
Electron microscopy. Mitochondria were fixed with
Trump buffer (1% glutaraldehyde, 4% formaldehyde, and
0.1 mol/L phosphate buffer [pH 7.2]), rinsed with phos-
phate-buffered sucrose, and postfixed in phosphate-buffered
1% osmium tetroxide. Samples were en bloc stained with
2% uranyl acetate for 30 minutes at 60°C, rinsed, dehydrat-
ed, and embedded in Spurr resin. Twelve thin sections for
each sample were cut on an Ultracut E ultramicrotome
(Reichert-Jung, Wien, Austria), placed on copper grids, and
stained with lead citrate. Isolated mitochondria were micro-
graphed with a JEOL EM-1200 EX II electron microscope
(JEOL USA, Inc, Peabody, Mass), and greater than 500
mitochondria were examined under each experimental con-
dition. Mitochondrial structure was defined as intact,
swollen, or damaged. Intact mitochondria were defined as
those with uninterrupted outer and inner membranes, thin
intermembrane space, and regular cristae enfolding into a
compact matrix. Swollen mitochondria were defined as dis-
tended mitochondria with increased intermembrane space
and swollen cristae. Damaged mitochondria were defined as
those with damaged outer and inner membranes, disrupted
matrices, and amorphous cristae.
Drugs. Diazoxide was purchased from Research
Biochemicals International (Natick, Mass) and dissolved as a
concentrated stock solution in dimethyl sulfoxide (DMSO).
The maximal concentration of DMSO within the incubation
medium was kept under 0.5%, and control experiments were
performed with corresponding DMSO concentrations. All
other chemicals were from Sigma Chemical Company (St
Louis, Mo).
Statistical analysis. Data are presented as means ± SEM,
and n represents the number of mitochondrial isolations used
for functional study or the actual number of imaged mito-
chondria in electron micrographs. Group comparisons were
performed by analysis of variance with the Student-Newman-
Keuls post hoc correction procedure.
Results
Anoxia reduces oxidative phosphorylation.  Oxida-
tive phosphorylation was assessed by monitoring
ADP-stimulated changes in the rate of mitochondrial
oxygen consumption and membrane potential before
and after anoxia-reoxygenation (Fig 1). Under nor-
moxic conditions (control), the rate of oxygen con-
Fig 1. Anoxia impairs ADP-initiated oxidative phosphorylation in isolated cardiac mitochondria. Mitochondria (2
mg of protein) were stirred in an airtight close chamber (1 mL), and the concentration of oxygen within the sus-
pension and the membrane potential of mitochondria were monitored simultaneously in control conditions (left
panel) or after 20 minutes of anoxia in reoxygenation (right panel). In control mitochondria addition of 250 µmol/L
ADP vigorously activated respiration, which induced a rapid decline in oxygen concentration (upper left). In reoxy-
genation, after anoxia, 250 µmol/L ADP produced only marginal acceleration of oxygen consumption (upper
right). ADP-stimulated membrane depolarization was significantly attenuated in anoxic-reoxygenated mitochon-
dria (lower right) compared with control mitochondria (lower left).
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sumption (state 2 respiration) was 31 ± 3 ng-atoms 
O2 · min–1 · mg–1 protein (Fig 1, left panel). Addition of
250 µmol/L ADP, the substrate of oxidative phos-
phorylation, increased oxygen consumption (state 3
respiration) to 291 ± 14 ng-atoms O2 · min–1 · mg–1 pro-
tein (n = 10; Fig 1, left panel). In normoxia mitochon-
drial membrane potential at steady-state was –192 ± 2
mV and reversibly depolarized (by up to 8 ± 3 mV) on
addition of ADP (250 µmol/L), reflecting ADP to ATP
conversion (Fig 1, left panel). On average, ADP stimu-
lated the rate of mitochondrial respiration by 838% and
caused transient depolarization lasting 36 ± 2 seconds
(n = 10). This indicates a vigorous capacity of normox-
ic mitochondria to phosphorylate added ADP.
After 20 minutes of anoxia followed by reoxygenation,
the rate of oxygen consumption was 57 ± 4 ng-atoms O2
· min–1 · mg–1 protein and increased to 141 ± 15 ng-atoms
O2 · min–1 · mg–1 on addition of 250 µmol/L ADP (Fig 1,
right panel). Thus anoxia-reoxygenation induces a 52%
decrease (P < .05) in ADP-stimulated respiration when
compared with normoxic mitochondria (n = 10). At the
end of the 20-minute period of anoxia, the mitochondrial
membrane potential was –170 ± 1 mV and returned to
–190 ± 3 mV on reoxygenation (n = 10; Fig 1, right
panel). ADP-stimulated membrane depolarization was
significantly attenuated in anoxic-reoxygenated mito-
chondria (3 ± 1 mV, P < .05), and the duration of depo-
larization was significantly prolonged (128 ± 11 seconds,
Fig 2. Diazoxide preserves ADP-stimulated respiration in postanoxic mitochondria. A, Changes in oxygen concen-
tration induced by 250 µmol/L ADP added after 20 minutes of anoxia in the absence (– Diaz) or presence (+ Diaz)
of 100 µmol/L diazoxide and compared with control values. B, Diazoxide (100 µmol/L) maintained the rate of ADP-
and DNP-stimulated respiration in postanoxic mitochondria to levels similar to those measured before anoxia. C,
ADP-induced mitochondrial membrane depolarization in postanoxic mitochondria in the absence (– Diaz) and pres-
ence (+ Diaz) of 100 µmol/L diazoxide. Mitochondrial depolarization was blunted and more prolonged in the absence
than in the presence of diazoxide. D, Diazoxide (100 µmol/L) maintained the amplitude and duration of ADP-induced
mitochondrial membrane depolarization in postanoxic mitochondria to levels similar to those measured before anox-
ia. In B and D, asterisks indicate significant difference from values obtained in control conditions (P < .05), whereas
C indicates control (normoxic) conditions.
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P < .05) compared with that of normoxic mitochondria
(Fig 1). This indicates an impaired capacity of mitochon-
dria to phosphorylate added ADP after an anoxia-reoxy-
genation insult.
Diazoxide preserves oxidative phosphorylation in
anoxic mitochondria. In contrast to mitochondria
exposed to anoxic stress in the absence of a potassium
channel opener, those treated with diazoxide throughout
the anoxic insult maintained a vigorous respiratory
response to ADP (250 µmol/L) after reoxygenation (Fig
2, A). Under these experimental conditions, the apparent
median effective concentration was 42 µmol/L, with the
maximal effect observed at 100 µmol/L diazoxide. In
100 µmol/L diazoxide–treated mitochondria, ADP-
stimulated respiration after anoxia was 255 ± 7 ng-
atoms O2 · min–1 · mg–1 protein (n = 10), a value signif-
icantly higher than that obtained in the absence of
diazoxide (P < .05) and similar to that of normoxic
mitochondria (P > .05; Fig 2, B). Similarly, mitochon-
dria treated with diazoxide (100 µmol/L) also preserved
Fig 3. Diazoxide preserves ATP production in anoxic mitochondria. A and B, Kinetics of ATP generation in control,
anoxic, and diazoxide-treated anoxic mitochondria. C, Chromatograms showing nucleotide profiles in anoxic mito-
chondria in the absence (– Diaz) or presence (+ Diaz) of 100 µmol/L diazoxide. ATP was higher and ADP was lower
in diazoxide-treated anoxic mitochondria compared with untreated anoxic mitochondria. D, Average rates of ATP
production. ATP production was measured from changes in reduced nicotinamide adenine dinucleotide phosphate
(NADPH) fluorescence in a coupled enzyme assay (A and B) or with high-performance liquid chromatography (C
and D). In B and D, asterisks indicate significant difference from values obtained in control conditions (P < .05),
whereas C indicates control (normoxic) conditions.
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their maximal rate of respiration after anoxia-reoxy-
genation, as determined by the rate of uncoupled oxy-
gen consumption in the presence of 50 µmol/L DNP
(Fig 2, B). DNP-stimulated respiration was 343 ± 8 ng-
atoms O2 · min–1 · mg–1 protein in diazoxide-treated
mitochondria compared with 359 ± 27 ng-atoms O2 ·
min–1 · mg–1 protein for normoxic mitochondria 
(P > .05) and 190 ± 19 ng-atoms O2 · min–1 · mg–1 pro-
tein for anoxic mitochondria in the absence of diazoxide
(P < .05, n = 10; Fig 2, B). Treatment with diazoxide
(100 µmol/L) also preserved ADP-stimulated mem-
brane depolarization of anoxic mitochondria both in
terms of amplitude (Fig 2, C) and duration (Fig 2, D).
Thus pretreatment with diazoxide reduced the decline in
ADP-stimulated respiration and associated membrane
depolarization in postanoxic mitochondria, suggesting
opener-mediated preservation of the oxidative phos-
phorylation capacity from anoxic insult.
Diazoxide preserves ATP production in anoxic
mitochondria. Monitoring of the kinetics of ATP gen-
eration indicated that anoxia produced significant
depression in the rate of oxidative phosphorylation (Fig
3, A). On average, anoxic stress halved the rate of mito-
chondrial ATP generation from 197 ± 11 U · min–1 ·
mg–1 before to 97 ± 11 U · min–1 · mg–1 protein after
anoxia (n = 9, P < .05; Fig 3, B). Diazoxide (100
µmol/L) attenuated anoxia-induced decrease in the rate
of oxidative phosphorylation and maintained mitochon-
drial ATP generation at 139 ± 9 U · min–1 · mg–1 protein
(n = 9; Fig 3, A and B). Consequently, the nucleotide
profile of anoxic mitochondrial preparations was shift-
ed from high ADP and low ATP levels in the absence of
diazoxide (Fig 3, C, upper trace) to low ADP and high
ATP levels in the presence of 100 µmol/L diazoxide
(Fig 3, C, lower trace). Accordingly, the rate of ATP
Fig 4. Diazoxide preserves the structural integrity of anoxic mitochondria. Transmission electron micrographs of
preanoxic (A), postanoxic (B), and diazoxide-treated postanoxic (C) mitochondria. (Original magnification
10,000×.) Mitochondria were defined as intact (I), swollen (S), or damaged (D). The majority of preanoxic mito-
chondria were intact, which was in contrast to damaged postanoxic mitochondria. Diazoxide (100 µmol/L) pre-
served the structural integrity of postanoxic mitochondria.
Fig 5. Diazoxide decreases leakage of a mitochondrial
protein from anoxic mitochondria. Adenylate kinase activity
was measured in mitochondria (Pellet) and in the extramito-
chondrial milieu (Super). Anoxia releases adenylate kinase
from mitochondria when compared with control values.
Diazoxide (Diaz; 100 µmol/L) prevents redistribution of
adenylate kinase, maintaining adenylate kinase in mitochon-
dria.
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synthesis was 640 ± 39 nmol ATP · min–1 · mg–1 protein
in diazoxide-treated anoxic mitochondria compared
with 752 ± 14 nmol ATP · min–1 · mg–1 protein for nor-
moxic mitochondria (P > .05) and 414 ± 34 nmol ATP
· min–1 · mg–1 protein for anoxic (P < .05) mitochondria
in the absence of diazoxide, respectively (n = 5; Fig 3,
D). Thus diazoxide prevents the decline in ATP synthe-
sis in postanoxic mitochondria.
Diazoxide preserves the structural integrity of
anoxic mitochondria. In normoxia 83% of isolated
mitochondria displayed intact morphology, with 17%
being swollen or damaged (n = 504; Fig 4, A). On reoxy-
genation and after 20 minutes of anoxia, 88% of mito-
chondria were damaged or swollen, with only 12%
remaining intact (n = 506; Fig 4, B). Diazoxide (100
µmol/L) preserved mitochondrial structure, and after
anoxia-reoxygenation, 67% of mitochondria remained
intact (n = 509; Fig 4, C). Under normoxia, adenylate
kinase activity, a marker of mitochondrial integrity, was
predominantly confined within mitochondria (1.23 ±
0.001 and 0.74 ± 0.008 mU · min–1 · mg–1 protein in the
mitochondrial pellet and supernatant, respectively).
After 20 minutes of anoxia, on reoxygenation, adenylate
kinase was released from mitochondria (0.65 ± 0.003
and 1.38 ± 0.005 mU · min–1 · mg–1 protein in the mito-
chondrial pellet and supernatant, respectively), indicat-
ing anoxia-induced damage to mitochondria. Diazoxide
(100 µmol/L) prevented release of adenylate kinase from
mitochondria (1.38 ± 0.005 and 0.74 ± 0.006 mU · min–1
· mg–1 protein in the mitochondrial pellet and super-
natant, respectively; Fig 5). Thus, diazoxide preserves
mitochondrial structural integrity and prevents release of
mitochondrial proteins after anoxic stress.
Discussion
The present study demonstrates that cardiac mito-
chondria can be protected from anoxic injury by the
mitochondrial potassium channel opener diazoxide.
Anoxic stress had a profound disruptive effect on mito-
chondrial structure and severely impaired oxidative
phosphorylation. However, treatment of mitochondria
with diazoxide during the anoxic period effectively
preserved the structural and functional integrity of
mitochondria, maintaining ATP generation after anoxic
insult. By protecting myocardial energetics under con-
ditions of reduced oxygen availability, diazoxide may
prove useful for improved intraoperative myocardial
protection and general myopreservation.
Mitochondrial dysfunction during global surgical
ischemia or cardiac storage for transplantation has been
associated with compromised myocardial viability and
impaired contractility.1,6,11,24,25 In this regard, mito-
chondrial structural and functional parameters have
been used to assess the protective efficacy of cardio-
plegic solutions,26-29 hypothermia,30-32 and/or assist
devices for hemodynamic support.33 Here we evaluated
the protective efficacy of a prototype mitochondrial
potassium channel opener on isolated mitochondria by
using a multiparametric approach that included mea-
surements of ADP-stimulated respiration, membrane
potential, ATP generation, adenylate kinase release,
and morphologic integrity. This is of importance
because mitochondrial ATP synthesis requires an intact
inner mitochondrial membrane and a maintained elec-
trochemical gradient supported by coupled respira-
tion.2 Dissipation of the electrochemical gradient and
uncoupling of respiration caused by disruption of the
inner mitochondrial membrane precipitates mitochon-
drial dysfunction with arrest of ATP production.2,3
Diazoxide was consistently effective in reducing anox-
ia-induced structural damage of cardiac mitochondria
and preserving mitochondrial oxidative phosphoryla-
tion, indicating a generalized protection of the
organelle from anoxic injury.
Diazoxide is an established member of the potassium
channel opener family.12 This class of agents has been
recognized for its powerful cardioprotective properties
and potential beneficial role as adjuncts to cardiople-
gia.1,6,7,9,10,34,35 The primary target of potassium chan-
nel opener action is believed to be the KATP channel, a
major metabolic sensor responsible for coupling cellu-
lar energetics with membrane excitability.36 Over-
expression of recombinant KATP channel subunits or
pharmacologic stimulation promotes cytoprotec-
tion,37,38 whereas genetic disruption or inhibition of
this ion conductance precipitates injury during meta-
bolic stress.39,40 In addition to the plasmalemmal KATP
channel, a subcellular target site for potassium channel
openers has more recently been recognized and associ-
ated with the inner mitochondrial membrane.41 This
putative mitochondrial KATP channel is particularly
sensitive to stimulation by diazoxide and has been
implicated in cardioprotection and ischemic precondi-
tioning.11-14,20,42,43 Although the protective effect of
diazoxide during ischemia and hypoxia has been so far
primarily evaluated in the whole heart,12 atrial trabecu-
lae,13 or single cardiomyocytes,14 the present study
provides direct evidence for a beneficial property of
this agent at the mitochondrial level itself. This is of
significance because it identifies mitochondria as the
target for diazoxide action without the confounding
contribution of cytoplasmic factors, such as nucleotides
and protein kinase C, which have been implicated in
modulating the outcome of opener action.17,44,45
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The molecular mechanism responsible for the pro-
tective effect of diazoxide on oxidative phosphoryla-
tion and the integrity of anoxic mitochondria remains
unknown. In normal mitochondria it has been
assumed that opening of mitochondrial potassium
channels promotes K+ influx dissipating the electro-
chemical H+ gradient and reducing the driving force
for ATP synthesis.15 However, on anoxia and reoxy-
genation, mitochondrial Ca2+ overload and excessive
generation of superoxide anions induces mitochon-
drial deterioration disrupting the inner membrane and
reducing oxidative phosphorylation.46,47 By prevent-
ing mitochondrial Ca2+ loading20 and reducing the
generation of reactive oxygen species,48 potassium
channel openers could maintain the structural and
functional integrity of cardiac mitochondria under
anoxic conditions. In this way diazoxide-mediated
protection of anoxic mitochondria may contribute to
improved cardiac bioenergetics and increased
myocardial resistance under conditions of reduced
oxygen supply.
In conclusion, this is a first report identifying the use
of a mitochondrial potassium channel opener as an effec-
tive means in protecting mitochondrial function and sus-
taining ATP production after anoxic stress. It should be
pointed out that the present study was conducted under
conditions of simulated anoxia in isolated mitochondria
suspended in experimental medium. In view of the
potential implications of the present findings toward a
safer cardioplegia and improved myopreservation, the
therapeutic profile of potassium channel openers needs
to be further tested in the whole heart in the setting of
global surgical ischemia, heart storage, or both. For a
potassium channel opener to be considered as an adjunct
to cardioplegia, rigorous comparative studies with other
cardioprotective agents are warranted.
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